日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

Hong Kong scientists discover deadly brain cancer mutation route

Xinhua | Updated: 2018-12-03 22:24
Share
Share - WeChat

HONG KONG -- The mutational mechanism of a rare and deadly brain cancer has been uncovered by scientists from the Hong Kong University of Science and Technology, providing new therapeutic lead to the disease.

Starting off at nerve cells around the spine and brain, lower-grade glioma (LGG) is the early form of sGBM -- one of the deadliest brain cancers. While sGBM can be treated with surgery or an oral chemotherapy drug, most of these malign tumors would mutate and return with mortality rate reaching almost 100 percent.

In their latest study made public on Monday, the team led by Wang Jiguang, assistant professor at the university's Division of Life Science and Department of Chemical and Biological Engineering, analyzed and integrated the genomic data of 188 sGBM patients, including newly collected samples from Chinese mainland and South Korean patients.

The study found that about 14 percent of the sampled sGBM patients displayed mutations in this gene.

Taking reference from this discovery, the university's collaborators, Jiang Tao and his team from Beijing Neurosurgical Institute and Beijing Tiantan Hospital, identified a drug molecule named PLB-1001 that can reach the tumors in the brain.

The molecule shows remarkable potency in selectively targeting sGBM tumors and those displaying further gene mutations.

The clinical trial of PLB-1001 on 18 recurrent patients at late cancer stage returned with a partial positive response in two patients.

After being prescribed a daily dosage ranging from 50 to 300 mg at Beijing Tiantan Hospital, the two patients experienced significant tumor shrinkage, with relieved symptoms and little side effects, lasting for more than 12 weeks.

The outcome of this clinical trial is significant in a sense that it furthers the knowledge about sGBM treatment, Wang said, adding that developing computational models on cancer evolution helps predict cancer cells' future behavior and prioritize treatment options.

Wang said more studies on PLB-1001 are needed to see if it can be used in conjunction with other drugs in achieving more persistent results.

The findings were published in scientific journal Cell on Nov 29.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 色综合久久综合网 | 国产 欧美 日韩 一区 | 欧美色欧美亚洲另类二区精品 | 久久久久99 | 国产成人在线影院 | 欧美一级久久 | 国产精品亚洲国产 | 偷拍自拍网址 | av中文字幕在线 | 亚洲区在线 | 黄页成人免费网站 | 日本高清在线精品一区二区三区 | 狠狠躁夜夜躁人人爽天天miya | 久久精品亚洲精品国产欧美kt∨ | 视频毛片| 欧美黄区| 精品日韩在线观看 | 视频精品一区 | 在线播放一区 | 91精品国产综合久久婷婷香蕉 | 国产高清在线看 | 香蕉久久一区二区不卡无毒影院 | 三级网站日本 | 青娱分类视频精品免费2 | 欧美色性| 日韩色区 | 日本99热| 日韩深夜福利 | 精品视频网站 | 特黄免费 | 一区二区三区视频在线观看 | 欧美日韩一区二区中文字幕 | 中文字幕在线一区二区三区 | 天堂资源8中文最新版 | 日韩欧美视频在线 | 自拍偷拍视频网站 | 精品欧美一区视频在线观看 | 亚洲性在线 | 欧美日韩专区国产精品 | 又大又紧又硬又湿a视频 | 99精品久久 |